BioAge Labs (BIOA) Other Non-Current Liabilities (2023 - 2026)
BioAge Labs (BIOA) posted Other Non-Current Liabilities of $477000.0 for Q1 2026, up 28.92% sequentially from $370000.0 in Q4 2025, and up 391.75% YoY from $97000.0 in Q1 2025.
BioAge Labs (BIOA) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
BioAge Labs has reported Other Non-Current Liabilities for 4 years, with the latest figure at $477000.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 391.75% year-over-year to $477000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $477000.0 (up 391.75% YoY) and the FY2025 annual result came in at $370000.0, up 137.18% from the prior year.
- Other Non-Current Liabilities grew to $477000.0 in Q1 2026 per BIOA's latest filing, from $370000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $613000.0 in Q3 2024 and troughed at $97000.0 in Q1 2025.
- A 4-year average of $275000.0 and a median of $192500.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities plunged 75.53% in 2025, then jumped 391.75% in 2026.
- Over 4 years, Other Non-Current Liabilities stood at $229000.0 in 2023, then slumped by 31.88% to $156000.0 in 2024, then surged by 137.18% to $370000.0 in 2025, then rose by 28.92% to $477000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $477000.0, $370000.0, and $150000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | BioAge Labs | 436.28 Mn | 436.28 Mn | -14.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 678,000.00 |
| Mar 31, 2026 | 477,000.00 |
| Dec 31, 2025 | 370,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 108,000.00 |
| Mar 31, 2025 | 97,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 613,000.00 |
| Dec 31, 2023 | 229,000.00 |